| 周涛斌,饶泉,谢邦椰,李淑慧,刘小敏.不同能量体外冲击波治疗髌骨软骨软化症的临床疗效和安全性[J].中国康复,2021,36(4):222-225 |
| 不同能量体外冲击波治疗髌骨软骨软化症的临床疗效和安全性 |
| Clinical efficacy and safety of different energy extracorporeal shock wave in the treatment of patellar malacia |
| |
| DOI： |
| 中文关键词: 体外冲击波 能量密流 髌骨软骨软化症 玻璃酸钠 |
| 英文关键词: extracorporeal shock wave therapy energy dense flow patellar chondromalacia sodium hyaluronate |
| 基金项目: |
|
| 摘要点击次数: 5653 |
| 全文下载次数: 4539 |
| 中文摘要: |
| 目的：观察不同能量体外冲击波治疗髌骨软骨软化症的临床疗效和安全性。方法：选取120例髌骨软骨软化症患者，随机分为A、B、C组各40例。A组采用低能量冲击波治疗，B组采用中能量冲击波治疗，C组采用玻璃酸钠关节腔内注射治疗。治疗前后采用股四头肌峰力矩（PT）、视觉模拟量评分法(VAS)、Lysholm评分量表进行评估；观察记录治疗和随访期间并发症发生情况。结果：治疗后3组患者PT值均较治疗前增加(均P＜0.05)，A组PT值明显高于B组和C组，B组PT值高于C组(P＜0.05)；治疗结束时和治疗后6个月，A组VAS评分均低于B组和C组(均P＜0.05)，B组和C组VAS评分差异无统计学意义；治疗后3组患者Lysholm评分均较前升高(均P＜0.05)；A组Lysholm评分高于B组和C组，B组Lysholm评分高于C组(P＜0.05)；3组患者并发症发生率两两比较差异无统计学意义。结论：ESWT能有效治疗髌骨软骨软化症，安全性与玻璃酸钠关节腔内注射相当；低能量冲击波治疗髌骨软骨软化症疗效优于中能量，两种能量安全性相当。 |
| 英文摘要: |
| Objective: To observe the efficacy and safety of different energy extracorporeal shock wave (ESW) in the treatment of chondromalacia patella. Methods: Totally 120 cases of chondromalacia patella were selected, and randomly divided into groups A, B and C (40 cases each). The group A was treated with low ESW, the group B with medium ESW, and the group C with intraarticular injection of sodium hyaluronate. The quadriceps femoris peak moment, visual analogue scale （VAS） and Lysholm scale were used before and after treatment. The complications during treatment and follow-up were recorded. Results: The PT value in all three groups after treatment was increased (P<0.05). The PT value in the group A was significantly higher than that in the group B and group C (P<0.05). The VAS scores in the group A were lower than those in the group B and group C (P<0.05) at the end of treatment and 6 months after treatment. There was no significant difference between the group B and group C. The Lysholm score in the three groups after treatment was higher than that before the treatment (P<0.05). The Lysholm score in the group A was higher than that in the group B and group C (P<0.05). There was no significant difference in the incidence of complications among the three groups. Conclusion: ESW treatment can effectively treat patellar chondromalacia, and the safety is comparable to that of sodium hyaluronate intraarticular injection. The low ESW is superior to medium ESW in the treatment of patellar chondromalacia, and the safety of two kinds of energy are equivalent. |
|
查看全文
下载PDF阅读器 HTML全文 |
| 关闭 |
